UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Current Status of US and Global Access to Direct‐Acting Antiviral Regimens for Hepatitis C Virus Infection

Clinical liver disease (Malden, Mass.), 2020-07, Vol.16 (1), p.16-19

Graham, Camilla S.

2020

Volltextzugriff (PDF)

Localized US Efforts to Eliminate Hepatitis C

Infectious disease clinics of North America, 2018-06, Vol.32 (2), p.293-311

2018

Volltextzugriff (PDF)

Removing the Barriers from the Path to Eliminate Hepatitis C

Infectious disease clinics of North America, 2018-06, Vol.32 (2), p.xv-xvi

2018

Volltextzugriff (PDF)

Implementing Adult Hepatitis B Immunization and Screening Using Electronic Health Records: A Practical Guide

Vaccines (Basel), 2024-05, Vol.12 (5), p.536

2024

Volltextzugriff (PDF)

A path to eradication of hepatitis C in low- and middle-income countries

Antiviral research, 2015-07, Vol.119, p.89-96

2015

Volltextzugriff (PDF)

Universal Screening for Hepatitis C Virus Infection: A Step Toward Elimination

JAMA : the journal of the American Medical Association, 2020-03, Vol.323 (10), p.936

2020

Volltextzugriff (PDF)

Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses

Journal of Virology, 2007-06, Vol.81 (11), p.5882-5892

2007

Volltextzugriff (PDF)

Making Do With What We Have

Annals of internal medicine, 2017-06, Vol.166 (11), p.850

Graham, Camilla S

2017

Volltextzugriff (PDF)

Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States

Infectious agents and cancer, 2016-05, Vol.11 (24), p.24, Article 24

2016

Volltextzugriff (PDF)

Hepatitis C and HIV co-infection: closing the gaps

JAMA : the journal of the American Medical Association, 2015-03, Vol.313 (12), p.1217

Graham, Camilla S

2015

Volltextzugriff (PDF)

Imported Fasciola hepatica Infection in the United States and Treatment with Triclabendazole

Clinical infectious diseases, 2001-07, Vol.33 (1), p.1-5

2001

Volltextzugriff (PDF)

Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients

Journal of Virology, 2004-11, Vol.78 (22), p.12252-12258

2004

Volltextzugriff (PDF)

Kinetics of Intrahepatic Hepatitis C Virus (HCV)-Specific CD4+ T Cell Responses in HCV and Schistosoma mansoni Coinfection: Relation to Progression of Liver Fibrosis

The Journal of infectious diseases, 2004-04, Vol.189 (7), p.1140-1150

2004

Volltextzugriff (PDF)

Urgent need for lived experience in hepatitis B guideline development

The lancet. Gastroenterology & hepatology, 2024-04, Vol.9 (4), p.282-284

2024

Volltextzugriff (PDF)

Overcoming Barriers to Eliminate Hepatitis C

Infectious disease clinics of North America, 2018-06, Vol.32 (2), p.i-i

2018

Volltextzugriff (PDF)

CD8+ Cell Responses to Hepatitis C Virus (HCV) in the Liver of Persons with HCV-HIV Coinfection versus HCV Monoinfection

The Journal of infectious diseases, 2005-03, Vol.191 (5), p.702-709

2005

Volltextzugriff (PDF)

New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management

Clinical chemistry, 2017-12, Vol.63 (12), p.1799-1805

2017

Volltextzugriff (PDF)

Comparison of current US risk strategy to screen for hepatitis C virus with a hypothetical targeted birth cohort strategy

American journal of public health (1971), 2012-11, Vol.102 (11), p.e101-e106

2012

Volltextzugriff (PDF)

Letter to the Editor: Hepatitis C Virus Prevalence Estimates Among Incarcerated Persons

Hepatology (Baltimore, Md.), 2019-08, Vol.70 (2), p.758-759

2019

Volltextzugriff (PDF)

Treatment with a Broad-Spectrum Cephalosporin versus Piperacillin-Tazobactam and the Risk for Isolation of Broad-Spectrum Cephalosporin-Resistant Enterobacter Species

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.1882-1886

2003

Volltextzugriff (PDF)

Effect of Exposure to Injection Drugs or Alcohol on Antigen-Specific Immune Responses in HIV and Hepatitis C Virus Coinfection

The Journal of infectious diseases, 2007-03, Vol.195 (6), p.847-856

2007

Volltextzugriff (PDF)

Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study

Journal of managed care & specialty pharmacy, 2016-06, Vol.22 (6), p.714-722b

2016

Volltextzugriff (PDF)

Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic States

Clinical infectious diseases, 2016-05, Vol.62 (10), p.1290-1296

2016

Volltextzugriff (PDF)

Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing

Clinical infectious diseases, 2017-01, Vol.64 (1), p.92-99

2017

Volltextzugriff (PDF)

Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus–specific T cell response kinetics

Hepatology (Baltimore, Md.), 2004-06, Vol.39 (6), p.1721-1731

2004

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Englisch
(159)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The Current Status of US and Global Access to Direct‐Acting Antiviral Regimens for Hepatitis C Virus Infection

Localized US Efforts to Eliminate Hepatitis C

Removing the Barriers from the Path to Eliminate Hepatitis C

Implementing Adult Hepatitis B Immunization and Screening Using Electronic Health Records: A Practical Guide

A path to eradication of hepatitis C in low- and middle-income countries

Universal Screening for Hepatitis C Virus Infection: A Step Toward Elimination

Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses

Making Do With What We Have

Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States

Hepatitis C and HIV co-infection: closing the gaps

Imported Fasciola hepatica Infection in the United States and Treatment with Triclabendazole

Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients

Kinetics of Intrahepatic Hepatitis C Virus (HCV)-Specific CD4+ T Cell Responses in HCV and Schistosoma mansoni Coinfection: Relation to Progression of Liver Fibrosis

Urgent need for lived experience in hepatitis B guideline development

Overcoming Barriers to Eliminate Hepatitis C

CD8+ Cell Responses to Hepatitis C Virus (HCV) in the Liver of Persons with HCV-HIV Coinfection versus HCV Monoinfection

New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management

Comparison of current US risk strategy to screen for hepatitis C virus with a hypothetical targeted birth cohort strategy

Letter to the Editor: Hepatitis C Virus Prevalence Estimates Among Incarcerated Persons

Treatment with a Broad-Spectrum Cephalosporin versus Piperacillin-Tazobactam and the Risk for Isolation of Broad-Spectrum Cephalosporin-Resistant Enterobacter Species

Effect of Exposure to Injection Drugs or Alcohol on Antigen-Specific Immune Responses in HIV and Hepatitis C Virus Coinfection

Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study

Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic States

Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing

Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus–specific T cell response kinetics

Suchergebnisse filtern